{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:35:01Z","timestamp":1794062101464,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ygyno.2012.04.036","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T22:43:10Z","timestamp":1335825790000},"page":"211-216","source":"Crossref","is-referenced-by-count":98,"title":["Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: Efficacy and toxicity of a low cumulative radiation dose schedule"],"prefix":"10.1016","volume":"126","author":[{"given":"Takafumi","family":"Toita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsutaro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Umayahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.04.036_bb0005","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1200\/JCO.2007.10.8324","article-title":"Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions","volume":"25","author":"Monk","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ijrobp.2007.10.045","article-title":"Patterns of radiotherapy practice for patients with cervical cancer (1999\u20132001): patterns of care study in Japan","volume":"70","author":"Toita","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijrobp.2010.10.030","article-title":"International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)","volume":"82","author":"Viswanathan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/cncr.22054","article-title":"Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer","volume":"107","author":"Stewart","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ygyno.2004.11.046","article-title":"Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer","volume":"96","author":"Toita","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ygyno.2007.01.032","article-title":"Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer","volume":"105","author":"Novetsky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0035","first-page":"196","article-title":"Treatment results and prognostic factors for cervical cancer patients treated by radiochemotherapy with weekly cisplatin","volume":"28","author":"Ozsaran","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijrobp.2008.06.1920","article-title":"Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution","volume":"74","author":"Parker","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0045","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ijrobp.2006.07.004","article-title":"Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications","volume":"66","author":"Chen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0050","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2011.04.047","article-title":"Outcomes of chemoradiotherapy in cervical cancer\u2014the Western Australian experience","volume":"82","author":"Lim","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0055","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ijrobp.2009.02.044","article-title":"Does the entire uterus need to be treated in cancer of the cervix? Role of adaptive brachytherapy","volume":"76","author":"Anker","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0060","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/IGC.0b013e3181e6f321","article-title":"Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix","volume":"20","author":"Forrest","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0065","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0360-3016(93)90462-5","article-title":"Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix","volume":"27","author":"Souhami","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0070","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1200\/JCO.2004.00.0497","article-title":"Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study","volume":"23","author":"Lanciano","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ygyno.2007.10.011","article-title":"Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g\/dL with erythropoietin vs above 10.0 g\/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer","volume":"108","author":"Thomas","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0080","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ygyno.2006.06.017","article-title":"Gynecologic Oncology Group. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I\/II study of the Gynecologic Oncology Group","volume":"103","author":"DiSilvestro","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2008.09.035","article-title":"Gynecologic Oncology Group. A phase I\/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study","volume":"112","author":"Walker","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2006.08.002","article-title":"A phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128","volume":"67","author":"Gaffney","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0095","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clon.2010.05.017","article-title":"Late complications from chemoradiotherapy for cervical cancer: reflections from cervical cancer survivors 10 years after the national cancer institute alert","volume":"22","author":"Vale","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijrobp.2006.12.021","article-title":"Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours","volume":"68","author":"Viswanathan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0110","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0360-3016(03)00288-8","article-title":"Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule","volume":"56","author":"Toita","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cncr.20734","article-title":"Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix","volume":"103","author":"Nakano","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1259\/0007-1285-11-132-809","article-title":"A dosage system for use in the treatment of cancer of the uterine cervix","volume":"11","author":"Tod","year":"1938","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0130","series-title":"ICRU report 38","first-page":"11","article-title":"Dose and volume specification for reporting intracavitary therapy in gynecology","author":"International Commission on Radiation Units and Measurements","year":"1985"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10147-011-0196-4","article-title":"Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG1066): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer","volume":"16","author":"Toita","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0140","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/1097-0142(19901215)66:12<2451::AID-CNCR2820661202>3.0.CO;2-5","article-title":"The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey","volume":"66","author":"Coia","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0145","first-page":"751","article-title":"The 38th annual report of gynecologic tumors committee","volume":"56","year":"2004","journal-title":"Acta Obstet Gynaecol Jpn"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2009.01.043","article-title":"Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society","volume":"76","author":"Viswanathan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2009.07.001","article-title":"Dose\u2013effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy","volume":"93","author":"Dimopoulos","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2012.04.036_bb0160","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ijrobp.2008.10.085","article-title":"Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival","volume":"74","author":"Narayan","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812003241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812003241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T14:20:51Z","timestamp":1542982851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812003241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0090825812003241"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.04.036","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}